Literature DB >> 14007700

Immunological studies with group B arthropod-borne viruses. I. Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with Japanese encephalitis virus.

C L WISSEMAN, B H SWEET, M KITAOKA, T TAMIYA.   

Abstract

Entities:  

Keywords:  ENCEPHALITIS, JAPANESE B/immunology; YELLOW FEVER/immunology

Mesh：

Substances：

Year:  1962        PMID： 14007700

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  11 in total

1.  Yellow fever vaccine seroconversion in travelers.

Authors:  Allison Kay; Lin H Chen; Maggie Sisti; Thomas P Monath
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity.

Authors:  T P Monath; D C Wilson; J Casals
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

3.  Group B arbovirus structural and nonstructural antigens. 3. Serological specificity of solubilized intracellular viral proteins.

Authors:  A A Qureshi; D W Trent
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

4.  Laboratory infection with Zika virus after vaccination against yellow fever.

Authors:  A R Filipe; C M Martins; H Rocha
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Authors:  F Guirakhoo; J Arroyo; K V Pugachev; C Miller; Z X Zhang; R Weltzin; K Georgakopoulos; J Catalan; S Ocran; K Soike; M Ratterree; T P Monath
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing.

Authors:  D W Trent
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

7.  Group B arbovirus structural and nonstructural antigens. II. Purification of Saint Louis encephalitis virus intracellular antigens.

Authors:  A A Qureshi; D W Trent
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

8.  Virion and soluble antigens of japanese encephalitis virus.

Authors:  K H Eckels; F M Hetrick; P K Russell
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

9.  In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.

Authors:  Stephen S Whitehead; Anna P Durbin; Kristen K Pierce; Dan Elwood; Benjamin D McElvany; Ellen A Fraser; Marya P Carmolli; Cecilia M Tibery; Noreen A Hynes; Matthew Jo; Janece M Lovchik; Catherine J Larsson; Elena A Doty; Dorothy M Dickson; Catherine J Luke; Kanta Subbarao; Sean A Diehl; Beth D Kirkpatrick
Journal:  PLoS Negl Trop Dis       Date:  2017-05-08

10.  SARS-CoV-2 vaccination in the context of original antigenic sin.

Authors:  Marek Petráš; Ivana Králová Lesná
Journal:  Hum Vaccin Immunother       Date:  2021-07-09       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.